Bioprosthetic Aortic Valve on the Move

Sep 19, 2022 | CASE

Surgery is the mainstay of treatment for patients with acute aortic regurgitation (AR). Bioprosthetic valves (BVs) demonstrate an excellent profile in terms of hemodynamics and seem to be a good fit for patients with high risk of bleeding. Nonetheless, the durability of BVs is limited compared to mechanical valves; inevitably, BV degeneration may lead to significant complications requiring major surgical reintervention.